• Arbitrum, Cardano, Pepe, Shiba Inu and Compound have notably low activity in their tokens, according to on-chain analysts at Santiment. 
• Analysts state that cold assets with low levels of activity in the past 90 days are in the buy zone. 
• Among 180 altcoins, ARB, ADA, PEPE, SHIB and COMP stood out as the coldest assets, as seen in the asset activity matrix.

Bitcoin price tumbled to $26,110, early on Monday, traders are likely to shift their attention to altcoins, looking for price gains. On-chain intelligence tracker Santiment, developed an “Asset Activity Matrix,” a tool that compares over 180 altcoins, to identify assets with high and low activity.

The tool can be used to identify altcoins that are in the buy zone and likely have the potential to yield gains for holders. Based on data for the past 90 days, Arbitrum (ARB), Cardano (ADA), PEPE meme coin, Shiba Inu (SHIB) and Compound (COMP) are the top five altcoins in the list.

Also read: FTX fights to clawback $157 million from former employees while creditors struggle with $7.9 billion in claims

ARB, ADA, PEPE, SHIB and COMP are in the buy zone

Analysts at Santiment classified altcoins as hot and cold, based on the activity in the protocol. Higher activity assets are associated with profit-taking and “selling,” similarly cold assets are in the “buy zone.”

Altcoins ARB, ADA, PEPE, SHIB and COMP, stand out in the asset activity tracker, as cold assets. These tokens have recorded notably low levels of activity from users, in the past 90 days. 

In the chart below, a higher density of blue squares is an easy way to identify cold assets, similarly yellow, orange and deep orange squares help define hot assets. 

Santiment Asset Activity Tracker

Notable developments in the cold assets are Chainlink mainnet rollout on Arbitrum One, Cardano’s consistent development activity on Github, PEPE price recovery after mass sell-off by former team members, and Shibarium relaunch, among others. These developments are likely to catalyze a recovery in the assets that are in the buy zone.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.